Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method

Lesego Tshweu, Lebogang Katata, Lonji Kalombo, Diego A. Chiappetta, Christian Hocht, Alejandro Sosnik, Hulda Swai

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: To encapsulate efavirenz (EFV) within poly(epsilon-caprolactone) (PCL) nanoparticles (NPs) and compare the oral pharmacokinetics with that of EFV-loaded micelles and pure EFV NPs. Materials & methods: EFV-loaded PCL NPs were produced by a double-emulsion/spray-drying method. Results: NPs displayed a hydrodynamic diameter of 200-250 nm. The encapsulation efficiency was 86-93% and the mass recovery was above 60%. X-ray diffraction indicated that drug and PCL underwent amorphization during the spray-drying process. Encapsulation within NPs significantly increased the maximum concentration in plasma and the bioavailability. Conclusion: EFV-loaded PCL NPs represent a promising platform to develop scalable pharmaceuticals with improved (bio)pharmaceutic performance.

Original languageEnglish
Pages (from-to)1821-1833
Number of pages13
JournalNanomedicine
Volume9
Issue number12
DOIs
StatePublished - 1 Aug 2014

Keywords

  • Efavirenz •
  • Hiv •
  • In vitro drug release •
  • Oral bioavailability enhancement •
  • Poly(epsilon-caprolactone) nanoparticle •
  • Spray drying

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • General Materials Science

Fingerprint

Dive into the research topics of 'Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method'. Together they form a unique fingerprint.

Cite this